Clinical Trial Update: A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and efficacy of alprostadil liposomes for injection to treat lower extremity arteriosclerosis obliterans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriosclerosis Obliterans

Drugs mentioned

• Alprostadil Liposomes for Injection (alprostadil liposome)

Snippet

Sponsor: Guangzhou Yipinhong Pharmaceutical CO.,LTD | Conditions: Arteriosclerosis Obliterans | Phase 2 | Status: UNKNOWN